Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island
NCT ID: NCT05413694
Last Updated: 2022-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
450 participants
INTERVENTIONAL
2022-07-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Reunion has a specific island context both climato-geographically and demographically. Indeed, this French island located in the southern hemisphere in the middle of the Indian Ocean (OI) has a tropical climate and a multi-ethnic population, younger than in mainland France (16% are over 60 years old). It is also marked by a higher prevalence in the general population of certain risk factors, such as obesity (11%) and type 2 diabetes (\>10%), recognized as factors favoring severe clinical forms of COVID-19. as well as "persistent COVID-19".
This study will allow the constitution of a large-scale French cohort located in a closed overseas territory to provide answers to local specificities and to the management of the epidemic in the territory.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
NCT03226314
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02839980
Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study
NCT04430322
Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic Fibrosis
NCT06371261
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02840656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
telephone interview 24 months after hospitalization for Covid-19
telephone interview 24 months after hospitalization for Covid-19
telephone interview 24 months after hospitalization for Covid-19
telephone interview 24 months after hospitalization for Covid-19
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
telephone interview 24 months after hospitalization for Covid-19
telephone interview 24 months after hospitalization for Covid-19
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having been hospitalized at the University Hospital Center (CHU) of Reunion (minimum of one night in the hospital)
* with a positive diagnosis of COVID-19 (positive RT(reverse transcription)-PCR(Polymerase Chain Reaction) SARS-CoV-2 on a nasopharyngeal swab or positive serology or confirmed diagnosis in the medical file)
* registered in the COVIDEPI database
* whose telephone numbers are available in the computerized patient file
* residing on the island of Reunion
* knowing how to understand and speak French
Exclusion Criteria
* opposing the use of their data
* deprived of liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure: guardianship or curators
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de la Réunion
Saint-Pierre, , Reunion
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lucie AUZANNEAU
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/CHU/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.